Evidence map›Paper›PMID 33850239›Full record

ArticleScientific reports2021

Author Correction: Abatacept enhances blood regulatory B cells of rheumatoid arthritis patients to a level that associates with disease remittance.

Maha Fahad Alenazy, Fatemeh Saheb Sharif-Askari, Mohammed A Omair, Mohammad S El-Wetidy, Maha A Omair, Hussam Mitwalli, Saleh Al-Muhsen, Abeer Al-Masri, Qutayba Hamid, Rabih Halwani

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Maha Fahad AlenazyImmunology Research Lab, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Fatemeh Saheb Sharif-AskariSharjah Institute of Medical Research, University of Sharjah, Sharjah, United Arab Emirates.
Mohammed A OmairRheumatology Unit, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Mohammad S El-WetidyImmunology Research Lab, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Maha A OmairDepartment of Statistics and Operations Research, College of Science, King Saud University, Riyadh, Saudi Arabia.
Hussam MitwalliImmunology Research Lab, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Saleh Al-MuhsenImmunology Research Lab, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Abeer Al-MasriDepartment of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Qutayba HamidSharjah Institute of Medical Research, University of Sharjah, Sharjah, United Arab Emirates.
Rabih HalwaniSharjah Institute of Medical Research, University of Sharjah, Sharjah, United Arab Emirates. rhalwani@sharjah.ac.ae.
King Saud University · SAUniversity of Sharjah · AEMcGill University Health Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33850239
PMCPMC8044154
OpenAlexW3156796094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.